Methods for treatment of recurrent hematological malignancies

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9844593
SERIAL NO

13988954

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Compositions comprising compounds that neutralize NK cell inhibitory receptors and methods of using such compositions in the treatment of hematological malignancies are provided.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
INNATE PHARMA SA117 AVENUE DE LUMINY MARSEILLE 13009

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Andre, Pascale Marseilles, FR 31 339
Buffet, Renaud Vanves, FR 10 32
Rozencweig, Marcel Marseilles, FR 12 175
Tiollier, Jerome Marseilles, FR 9 169

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Jun 19, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jun 19, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00